Literature DB >> 5054147

Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum.

G S Kobbayashi, G Medoff, D Schlessinger, C N Kwan, W E Musser.   

Abstract

Rifampicin, at high concentrations, inhibited growth and RNA synthesis in the yeast phase of Histoplasma capsulatum. These effects were potentiated by low concentrations of amphotericin B. The combination of the two agents was fungicidal, whereas each alone, at much higher concentrations, was only fungistatic.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5054147     DOI: 10.1126/science.177.4050.709

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  26 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

Review 2.  New antifungal therapy in ophthalmology.

Authors:  T W Lieberman; I H Leopold
Journal:  Trans Am Ophthalmol Soc       Date:  1973

3.  Differential potentiation by nystatin of the effect of antibiotics on yeast and mammalian cells.

Authors:  A Aszalos
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

Review 4.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

5.  In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

Authors:  Eric Dannaoui; Javier Afeltra; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  Ribonucleic acid synthesis dependent on exogenous triphosphates in nystatin-treated cells of of Kluyveromyces latis.

Authors:  G Badaracco; G Cassani
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

7.  Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine.

Authors:  J Arroyo; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

8.  In vitro inhibition of Coccidioides immitis strains with amphotericin B plus rifampin.

Authors:  D Rifkind; E D Crowder; R N Hyland
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

9.  Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus.

Authors:  M Kitahara; V K Seth; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

10.  Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.